Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CHMP recommendation
Pharma
Europe's CHMP gives nods to Novo's Kyinsu, Bayer's Lynkuet
Europe's CHMP has recommended several products for approval, including Novo Nordisk's diabetes drug Kyinsu and Bayer's menopause treatment Lynkuet.
Kevin Dunleavy
Sep 19, 2025 10:45am
ExCellThera's blood cancer cell therapy Zemcelpro earns EU nod
Aug 27, 2025 7:40am
Lilly's Kisunla, Gilead's PrEP drug Yeytuo gain CHMP nods
Jul 25, 2025 11:03am
Roche will continue seeking path forward for Elevidys in EU
Jul 25, 2025 9:55am
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Jun 20, 2025 11:55am
CHMP signs off on GSK's comeback ADC cancer drug Blenrep
May 23, 2025 11:23am
